Business
Delivra Health and its Brands LivRelief(TM) and Dream Water(TM) Report Results for Second Quarter of Fiscal 2025
Net revenue growth of 34% or $704 in the second quarter of fiscal 2025 compared to same quarter l...
About this update from Delivra Health Brands Inc
[{"type":"text","content":"Delivra Health and its Brands LivRelief(TM) and Dream Water(TM) Report Results for Second Quarter of Fiscal 2025Net revenue growth of 34% or $704 in the second quarter of fiscal 2025 compared to same quarter last yearSignificantly increased investments in marketing and consumer promotional programs to increase awareness of offered solutions On track to achieving commercial and financial objectives for fiscal yearVancouver, British Columbia--(Newsfile Corp. - February 27, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) (\"Delivra Health\" or the \"Company\"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial and operating results for the three and six months ended December 31, 2024 (\"Q2 2025\"). The Delivra Health portfolio features innovative brands Dream Water® and LivRelief™, which deliver relief from common health issues such as sleeplessness, chronic pain and anxiety.Management Commentary\"The Company's Q2 2025 results, achieving a 34% increase in revenue compared to the same quarter last year, further demonstrates the Company's positive growth trajectory. We remain on track to achieve our commercial and financial objectives for the fiscal year,\" said Gord Davey, President and Chief Executive Officer of Delivra Health. \"During Q2 2025, the Company increased its marketing spend and invested in consumer promotional programs across all channels. This complements our strategy of securing new product listings, expanding Delivra's customer base, and launching key initiatives to drive long-term growth.\" Financial Highlights for the Three Months Ended December 31, 2024(Expressed in thousands of Canadian dollars, except share and per share amounts)Net revenue: In the three months ended December 31, 2024, the Company reported total net revenue of $2,754 as compared to $2,050 in same period last year, representing approximately a $704 or 34% increase. This net increase was primarily due to higher sales of Dream Water® in the U.S. and Canada as a result of timing of customer ordering patterns offset by lower sales of the Company's licensed LivRelief™ infused topical creams in Canada. Gross profit and gross profit margin: In the three months ended December 31, 2024, the Company reported gross profit of $1,294 and a gross ...